FutureChem Co Ltd
KOSDAQ:220100
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (19.1), the stock would be worth ₩17 371.34 (8% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 20.6 | ₩18 800 |
0%
|
| 3-Year Average | 19.1 | ₩17 371.34 |
-8%
|
| 5-Year Average | 17.8 | ₩16 257.98 |
-14%
|
| Industry Average | 10.6 | ₩9 690.1 |
-48%
|
| Country Average | 1.3 | ₩1 170.2 |
-94%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
415.4B KRW | 20.6 | -98.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 362.1 | 4 280.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
175.6B USD | 4.5 | 26.2 | |
| US |
|
Danaher Corp
NYSE:DHR
|
126.4B USD | 5.6 | 34.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 17.9 | 46.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.3B CHF | 5.5 | -119.7 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
298.9B CNY | 5.8 | 15.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.3B USD | 4.8 | 25.1 | |
| US |
|
Waters Corp
NYSE:WAT
|
30.5B USD | 9.8 | 47.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.3B USD | 2.4 | 20.1 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.7B USD | 6.9 | 29.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.6 |
| Median | 1.3 |
| 70th Percentile | 2.8 |
| Max | 96 381.4 |
Other Multiples
FutureChem Co Ltd
Glance View
FutureChem Co., Ltd. engages in the manufacture of medical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-08-13. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The firm manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The firm also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.
